yorkshire_moors_dales_yorkshire_landscape_england_countryside_english_rural-497670

Those living in rural areas less likely to survive cancer, study shows

pharmafile | December 13, 2018 | News story | Medical Communications, Research and Development Cancer, health, oncology, rural, survival, urban 

Those living in rural areas are less likely to survive cancer than their city dwelling counterparts, according to new research by the University of Aberdeen.

The review, which examined 39 studies form developed countries, found that people living in rural locations were 5% less likely to survive cancer in comparison to those living in cities.

Around 20% of the world’s population live in rural areas. However the review found that 30 of the 39 studies showed there was a clear ‘survival disadvantage’ for those rural residents.

Advertisement

The study analysed a large variety of different cancer types and involved more than 2 million people. The review sought to explain the discrepancy in suggesting that poor transport links and proximity to health centres may cause delays in patients seeking treatment.

Lead Investigator Professor Peter Murchie, a GP and primary care cancer expert from the University of Aberdeen commented: “A previous study showed the inequality faced by rural cancer dwellers in north-east Scotland and we wanted to see if this was replicated in other parts of the world,”

“The task now is to analyse why this is the case and what can be done to close this inequality gap. In this paper we have considered some of the potential reasons but these must really be analysed in closer detail.”

Louis Goss

Related Content

Rethinking oncology trial endpoints with generalised pairwise comparisons

For decades, oncology trials have been anchored to a familiar set of endpoints. Overall survival …

drug-trials

Pharma&’s ovarian cancer therapy approved for use by NHS Scotland

Pharma& has announced that its treatment for ovarian cancer, Rubraca (rucaparib), has been accepted by …

drug-trials

Bio-Rad signs exclusive European distribution deal with Gencurix for oncology testing kits

The agreement expands access to oncology testing kits across Europe

The Gateway to Local Adoption Series

Latest content